↓ Skip to main content

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

Overview of attention for article published in Diabetologia, September 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy
2 policy sources
patent
9 patents

Citations

dimensions_citation
514 Dimensions

Readers on

mendeley
214 Mendeley
citeulike
1 CiteULike
connotea
1 Connotea
Title
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
Published in
Diabetologia, September 2006
DOI 10.1007/s00125-006-0416-z
Pubmed ID
Authors

I. Raz, M. Hanefeld, L. Xu, C. Caria, D. Williams-Herman, H. Khatami, Sitagliptin Study 023 Group

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 214 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 <1%
Netherlands 1 <1%
United Kingdom 1 <1%
Peru 1 <1%
Russia 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 206 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 34 16%
Student > Master 28 13%
Student > Bachelor 26 12%
Student > Ph. D. Student 22 10%
Other 17 8%
Other 43 20%
Unknown 44 21%
Readers by discipline Count As %
Medicine and Dentistry 73 34%
Agricultural and Biological Sciences 27 13%
Pharmacology, Toxicology and Pharmaceutical Science 15 7%
Nursing and Health Professions 11 5%
Biochemistry, Genetics and Molecular Biology 10 5%
Other 25 12%
Unknown 53 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#3,361,594
of 23,275,636 outputs
Outputs from Diabetologia
#1,565
of 5,116 outputs
Outputs of similar age
#7,485
of 68,137 outputs
Outputs of similar age from Diabetologia
#5
of 35 outputs
Altmetric has tracked 23,275,636 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,116 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.9. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 68,137 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.